Medwave Clinical Research


Medwave is recognized for the fact that dedicated oncology expertise is combined with central imaging review methodology knowledge. Our strength is that for full services studies including central imaging, we develop the EDC, the imaging upload tool and the central review system allowing that we avoid any data- entry redundancies for the sites and that reconciliation steps between the different data-sets is optimized.

We can offer experience in the following therapies:

  • Radiotherapy
  • Immunotherapy
  • Chemotherapy
  • Biologicals
  • Photodynamic therapy

And the following indications:

  • Neuroendocrine tumors (Percist)
  • Melanoma (Recist)
  • Breast (Recist)
  • Glioblastoma (RANO, modified RANO)
  • Lung cancer (Recist)
  • Ovarian cancer (irRECIST)
  • Hodgkin lymphoma (Cheson, Lugano, LyRIC)